AI-based wearable sensors for continuous monitoring of diabetes and cardiovascul...
AI-based wearable sensors for continuous monitoring of diabetes and cardiovascular diseases
Cardiovascular diseases (CVDs) are the leading cause of death in Europe, with a total of 3.9 million deaths yearly, accounting for 45% of all deaths. Diabetes is another widely spread disease affecting 60 million people in the EU...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
Elektrosens
Wearable Sweat based painless and continuous glucose monitor...
71K€
Cerrado
PDC2022-133429-I00
SISTEMA WEARABLE DE INTELIGENCIA ARTIFICIAL PARA LA TOMA DE...
135K€
Cerrado
CPP2021-008659
Hacia una nueva generación de soluciones digitales para la d...
275K€
Cerrado
KWatch Glucose
K Watch Glucose A ground breaking biometric wearable for pa...
71K€
Cerrado
PTQ2023-013156
Nuevas herramientas biosensoras para el diagnóstico remoto,...
109K€
Cerrado
PTQ2021-012005
Nuevas herramientas biosensoras para el diagnóstico remoto,...
100K€
Cerrado
Información proyecto SensCare
Duración del proyecto: 9 meses
Fecha Inicio: 2023-06-07
Fecha Fin: 2024-03-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Cardiovascular diseases (CVDs) are the leading cause of death in Europe, with a total of 3.9 million deaths yearly, accounting for 45% of all deaths. Diabetes is another widely spread disease affecting 60 million people in the EU (10% of the total population). Diabetes is the major cause of death in the age of 20-79. Also, Europe has the highest number of children with type-1 diabetes compared to other regions, with approximately 140,000 diagnosed children, and it has one of the highest prevalence rates of diabetes in children, with 21,600 new cases per year. Frequent glucose monitoring is critical for keeping blood glucose levels within a specific range to prevent potential cardiometabolic disease progression and pathophysiological changes. Current standard healthcare systems are passive and reactive, which deal with issues, incidents, and accidents after the opportunity to prevent damage to the patient has passed. With reactive healthcare, doctors provide treatment once patients contact them after developing noticeable symptoms. Actions are taken after things go wrong and sometimes after the opportunity to save the patient has passed. Besides, economically, reactive safety measures are costly in the long term. Moreover, this routine fails to prevent the onset of health conditions by prioritizing diagnostics and treatment.
SensAI aims to tackle the limitations of centralized and reactive healthcare systems by taking a proactive approach using tailored, non-invasive, and personalized solutions (wearable monitoring devices) specifically developed for diabetes and CVDs without affecting peoples’ daily routines.